awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q28710019-0105DE32-5B34-4CE5-B856-7C0DC067C5F6
Q28710019-0105DE32-5B34-4CE5-B856-7C0DC067C5F6
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28710019-0105DE32-5B34-4CE5-B856-7C0DC067C5F6
SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials
P2860
Q28710019-0105DE32-5B34-4CE5-B856-7C0DC067C5F6
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28710019-0105DE32-5B34-4CE5-B856-7C0DC067C5F6
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
6aba44523148542cf91808b3fa4fd2bf424ca475
P2860
Most tumour necrosis factor inhibitor trials in rheumatology are undeservedly called 'efficacy and safety' trials: a survey of power considerations.